Executive Summary
The September 21, 2026, filings reveal a strong wave of sector consolidation and strategic realignment in India, with 14 filings collectively indicating a shift towards high-growth verticals like renewable energy, defense, and specialty chemicals.
Period-over-period data shows a clear pattern: companies are divesting non-core assets (Thyrocare selling Nueclear Healthcare) while acquiring stakes in early-stage, high-potential sectors (Shekhawati in solar, Zodiac in battery storage). A notable trend is the use of share swaps and demergers (Kapil Raj Finance, Race Eco Chain, Himadri Speciality Chemical) to unlock value without cash outflows, suggesting balance sheet optimization. Insider activity is limited, but the mixed sentiment on the Himadri demerger and the positive outlook on Samvardhana Motherson's defense acquisition highlight key areas of management conviction. The most critical development is the Samvardhana Motherson deal, which values a defense connector maker at a 5x+ revenue multiple, signaling premium valuations for strategic assets. Overall, the market is witnessing a 'build vs. buy' strategy favoring acquisitions in sunrise sectors, with a focus on operational synergies and vertical integration.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A
Tracking the trend? Catch up on the prior India Sector Consolidation Regulatory Filings digest from September 19, 2026.
Investment Signals (12)
- Samvardhana Motherson International (SAMIL)▲
Acquiring 50.1% of Rotary Connectors (defense) for EV of INR 5,004 Mn; RCPL's revenue grew 20% YoY (FY26: INR 1,235 Mn vs FY25: INR 1,028 Mn) and 64% over two years, indicating strong momentum in defense electronics. The deal gives SAMIL control of a military-grade connector maker with no regulatory hurdles, a clear BULLISH signal for defense exposure.
- Himadri Speciality Chemical (HSCL)▲
Demerger of Dalmia Bharat Refractories' tyre business into HSCL (turnover INR 149.31 Cr, 3.39% of HSCL's total) creates vertical integration with carbon black operations. No cash outflow and share issuance to DBRL shareholders implies value creation without leverage. BULLISH for long-term synergy realization.
-
Acquired 100% of City Pro Group (US pediatric healthcare) with FY25 revenue of US$11.43 Mn (~₹97.27 Cr). Combined scale will significantly boost consolidated revenue; FY26 EPS of ₹3.21 provides a valuation anchor. The two-way India-US capability exchange is a unique BULLISH catalyst for cross-border healthcare delivery.
-
Divesting 100% of Nueclear Healthcare for ₹141.40 Cr (cash + CCPS). NHL's FY26 turnover of ₹44.62 Cr (5.38% of consolidated) and PAT margin of 10.9% is modest; the sale allows Thyrocare to focus on core pathology with higher margins. The slump sale structure avoids merger complexities. BULLISH for margin improvement.
-
Board approved up to 69% stake in Shekhawati New Energy LLP (solar/green energy). This is a related-party transaction at arm's length, signaling promoter confidence in the renewable pivot. The move diversifies from traditional textiles into a high-growth sector. BULLISH for sector rotation.
-
Completed 63.5% acquisition of Zenwatt Clean Energy (BESS) for ₹1.14 Cr. Zenwatt's FY26 turnover of only ₹5.13 Lakh (vs nil in prior years) indicates an early-stage bet. The low entry cost and related-party nature suggest a controlled experiment in battery storage. NEUTRAL-BULLISH if BESS market accelerates.
-
Acquiring 90% of Henyo Pack via share swap (100:1 ratio). Henyo's turnover declined sharply to ₹4,673.38 Lakh (FY25) from ₹2,836.41 Lakh (FY24), a red flag. The massive share issuance (up to 265 Cr shares) will dilute existing holders significantly. BEARISH for current shareholders.
-
Received 'no adverse observations' from BSE/NSE for demerger of Biomass and Restore Bag divisions into two new entities. The scheme unlocks value by creating pure-play green energy and packaging companies. The 6-month validity of the observation letter provides a clear catalyst timeline. BULLISH for value unlocking.
-
Raising up to ₹200 Cr via convertible warrants and incorporating a wealth management subsidiary with ₹120 Cr investment. The dual capital raise signals aggressive expansion into high-margin wealth management, but warrant pricing details are pending. NEUTRAL-BULLISH pending pricing terms.
-
Incorporated Adivistar Electronics (OEM for smartphones) with ₹2.55 Cr investment. The subsidiary has nil turnover, but Dixon's track record in electronics manufacturing suggests a strategic capacity addition. BULLISH for the Make-in-India theme.
-
Incorporated Ather Energy Hong Kong Ltd for APAC procurement. The move enhances supply chain resilience for EV components. While low materiality (HKD 16.5 Lakh), it signals international sourcing strategy. BULLISH for cost optimization.
-
Acquired dubbing rights for 'Anomie' (excluding South Indian languages). The deal expands content library but financial terms are undisclosed. Low materiality. NEUTRAL.
Risk Flags (9)
-
The 100:1 swap ratio for Henyo Pack acquisition implies massive dilution. Issuing up to 265 Cr shares at ₹1 face value will drastically reduce EPS for existing shareholders. Henyo's declining turnover (FY25: ₹4,673.38 Lakh vs FY24: ₹2,836.41 Lakh) adds operational risk. HIGH RISK.
-
Zenwatt Clean Energy's FY26 turnover of only ₹5.13 Lakh (vs nil in prior years) indicates negligible revenue. The ₹1.14 Cr investment for 63.5% stake is small but the BESS market is unproven at scale. HIGH RISK of capital being locked in a non-performing asset.
-
The demerger of DBRL's tyre business into HSCL requires approvals from stock exchanges, SEBI, NCLT, and shareholders. Any delay or rejection could impact the appointed date (Oct 1, 2026). The shareholding pattern change may create short-term overhang. MODERATE RISK.
-
The buyer, Trovera Healthcare, was incorporated on June 16, 2026, with no audited financials. The consideration includes 42,500 CCPS of Trovera (₹81.90 Cr), which is unlisted and illiquid. If Trovera fails to perform, Thyrocare could be left with worthless paper. HIGH RISK.
-
The demerger scheme is subject to NCLT filing and shareholder approvals. SEBI's comments on July 30, 2026, flagged compliance with LODR regulations and financial recency. Any non-compliance could delay or derail the scheme. MODERATE RISK.
-
The 69% stake in Shekhawati New Energy LLP is a related-party transaction (common directors). While stated at arm's length, minority shareholders may question governance. The renewable energy sector is capital-intensive and may require further funding. MODERATE RISK.
-
Acquiring 50.1% of Rotary Connectors (defense) requires seamless integration into SAMIL's existing auto components business. The promoters retaining 49.9% could lead to governance friction. The locked-box date (March 31, 2026) may create valuation disputes. MODERATE RISK.
-
The USD 7 Mn investment in US subsidiary is funded from IPO proceeds (INR 53 Cr). The subsidiary's turnover of INR 11.58 Mn (USD 11.58 Mn) is minimal. Any adverse forex movement could impact returns. LOW-MODERATE RISK.
-
The preferential warrant issue (₹200 Cr) and subsidiary incorporation (₹120 Cr) are approved but pricing and investor names are pending. If the warrant issue is undersubscribed, the wealth management expansion may be delayed. MODERATE RISK.
Opportunities (10)
-
Acquiring 50.1% of Rotary Connectors (military-grade connectors) at an EV of INR 5,004 Mn. RCPL's revenue CAGR of 28% over two years (FY24: INR 752 Mn to FY26: INR 1,235 Mn) indicates strong growth. The defense sector is a government priority, and SAMIL's global reach can scale RCPL's exports. OPPORTUNITY to play the defense indigenization theme.
-
The demerger of DBRL's tyre business into HSCL creates a carbon black-to-tyre value chain. HSCL's existing carbon black operations will benefit from captive demand. The no-cash structure preserves balance sheet strength. OPPORTUNITY for margin expansion through synergies.
-
The demerger of Biomass and Restore Bag divisions into separate listed entities will create pure-play green energy and packaging companies. The 'no adverse observation' from exchanges clears a major hurdle. OPPORTUNITY to invest in two focused businesses with distinct growth trajectories.
-
The acquisition of City Pro Group (US$11.43 Mn revenue) gives Mom's Belief a US foothold in pediatric healthcare. The two-way capability exchange (India-US) is unique. With FY26 EPS of ₹3.21, the stock may be undervalued relative to the combined scale. OPPORTUNITY for a healthcare consolidation play.
-
Divesting Nueclear Healthcare (5.38% of consolidated turnover) allows Thyrocare to focus on high-margin pathology. The cash component of ₹59.50 Cr strengthens the balance sheet. OPPORTUNITY for margin improvement and potential special dividend.
-
The 69% stake in Shekhawati New Energy LLP (solar/green energy) is a strategic shift from traditional textiles. The renewable energy sector in India is booming with government support. OPPORTUNITY for a low-cost entry into a high-growth sector.
-
The incorporation of Adivistar Electronics (OEM for smartphones) adds capacity. Dixon's existing relationships with global brands (e.g., Xiaomi, Samsung) provide a ready market. OPPORTUNITY to ride the PLI-driven electronics manufacturing boom.
-
The 63.5% stake in Zenwatt Clean Energy (BESS) at ₹18 per share is a low-cost entry into energy storage. With India's renewable energy targets, BESS demand is expected to surge. OPPORTUNITY for a high-risk, high-reward play on the energy transition.
-
The ₹120 Cr investment in a new wealth management subsidiary targets high-margin advisory fees. The ₹200 Cr warrant issue provides growth capital. OPPORTUNITY for revenue diversification beyond broking.
-
The Hong Kong subsidiary for APAC procurement reduces dependence on domestic suppliers. With EV adoption accelerating, cost optimization is critical. OPPORTUNITY for margin improvement through better sourcing.
Sector Themes (6)
- Renewable Energy Pivot◆
3 filings (Shekhawati Industries, Zodiac Energy, Race Eco Chain) involve renewable energy or green energy assets. Shekhawati's 69% stake in solar, Zodiac's 63.5% in BESS, and Race Eco's demerger of Biomass division indicate a clear shift towards green energy. Aggregate investment: ~₹1.14 Cr (Zodiac) + undisclosed (Shekhawati). Implication: Traditional companies are diversifying into renewables, creating a sub-sector of 'green spin-offs'.
- Defense & Aerospace Consolidation◆
Samvardhana Motherson's acquisition of Rotary Connectors (defense connectors) is the only pure defense play, but it signals growing interest in the sector. RCPL's revenue growth (20% YoY) and military-grade products command premium valuations (EV/Revenue ~4x). Implication: Defense is becoming a high-growth, high-valuation M&A target.
- Demerger & Value Unlocking◆
3 filings involve demergers (Himadri, Race Eco, Kapil Raj Finance). These schemes aim to unlock value by creating focused entities. Himadri's demerger of tyre business, Race Eco's split into green energy and packaging, and Kapil Raj's acquisition via share swap all use non-cash structures. Implication: Companies are using demergers to streamline operations and reward shareholders without cash outflows.
- Cross-Border Expansion◆
3 filings involve international subsidiaries (Purple Style Labs in US, Rays of Belief in US, Ather Energy in Hong Kong). Purple Style Labs invested USD 7 Mn in US subsidiary, Rays of Belief acquired US pediatric provider, Ather set up HK procurement arm. Implication: Indian companies are expanding globally to access new markets and supply chains, particularly in the US and APAC.
- Related-Party Transactions Dominance◆
4 filings involve related-party transactions (Shekhawati, Zodiac, Dixon, Kapil Raj). While stated at arm's length, the prevalence raises governance questions. Shekhawati's common directors, Zodiac's promoter interest, Dixon's wholly-owned subsidiary, and Kapil Raj's swap with Henyo all involve insiders. Implication: Investors should scrutinize valuations and minority interest protections.
- Capital Allocation Shift◆
Companies are using share swaps and demergers (non-cash) over cash acquisitions. Only Samvardhana Motherson (INR 5,004 Mn) and Thyrocare (₹141.40 Cr) involve significant cash. The preference for non-cash structures suggests balance sheet conservatism. Implication: Cash-rich companies may be hoarding for larger deals, while others use equity to preserve cash.
Watch List (8)
-
The demerger scheme requires NCLT approval. The 6-month validity of the observation letter (from Sep 21, 2026) sets a deadline. Watch for shareholder meeting dates and NCLT hearing schedules.
-
The demerger is effective from Oct 1, 2026. Watch for regulatory approvals (stock exchanges, SEBI, NCLT) and the record date for share issuance to DBRL shareholders.
-
The sale of Nueclear Healthcare requires shareholder approval. Watch for the EGM date and voting outcome. The transaction is expected to complete by Nov 30, 2026.
-
The acquisition of Rotary Connectors is expected to close by Q4 FY 2026-27. Watch for locked-box adjustments and board appointments. The 50.1% stake gives control but the 49.9% promoter retention may lead to governance updates.
-
The share swap acquisition requires stock exchange approval within 30 days. Watch for the approval timeline and the impact of massive dilution on share price.
-
The preferential issue of convertible warrants (₹200 Cr) requires pricing and investor names. Watch for the Finance Committee meeting to determine terms. The wealth management subsidiary incorporation also needs ROC approval.
-
The acquisition of City Pro Group (US) is effective Sep 18, 2026. Watch for consolidated revenue impact in Q3 FY27 results and any regulatory approvals for cross-border healthcare practices.
-
The USD 7 Mn investment requires approval from an authorized dealer bank under FEMA rules. Watch for completion within 30 days of approval. Any delay could impact the US subsidiary's operations.
Filing Analyses
(14)
21-09-2026
Purple Style Labs Ltd's board approved a USD 7 million investment in its wholly owned US subsidiary, Purple Style Labs USA Inc., via the acquisition of 7 million Class B Common Stock. The investment will be primarily funded from IPO proceeds (INR 530 million) and used for the subsidiary's general corporate purposes. The subsidiary, which operates a Pernia's Pop-Up Studio retail experience in New York City, reported a turnover of INR 11.58 million (USD 11.58 million) for its first partial year of operations (April 2025–March 2026).
- · PSL USA was incorporated on April 16, 2025, as a Delaware Corporation.
- · PSL USA's share capital comprises 10,000,000 Class A Common Stock ($0.00001 par value each) and 2,000,000 Class B Common Stock ($1 par value each).
- · The investment requires approval from an authorized dealer bank under Foreign Exchange Management (Overseas Investment) Rules, 2022, with completion expected within 30 days of receiving that approval.
- · The transaction is considered a related party transaction (PSL USA is a wholly owned subsidiary) but is stated to be at arm's length and in line with IPO objects.
- · Promoter Abhishek Agarwal serves as President, Secretary and Treasurer of PSL USA.
21-09-2026
Shekhawati Industries Ltd's Board approved subscribing as a partner in the proposed Shekhawati New Energy LLP, with an investment of up to 69% stake. The investment is in the mega solar/green energy sector, is a related party transaction (at arm's length), and will be for cash consideration. The move aims to create operational synergy and expertise in renewable energy.
- · The investment is a related party transaction as directors are common in the entities.
- · The investment is for cash consideration.
- · The target entity, Shekhawati New Energy LLP, is a proposed professional renewable energy company focusing on solar and green energy solutions.
- · No governmental or regulatory approvals are required for the investment.
- · The indicative time period for completion is post incorporation of the LLP.
21-09-2026
Zodiac Energy Limited has completed the acquisition of a 63.5% majority equity stake in Zenwatt Clean Energy Private Limited, making it a subsidiary effective September 21, 2026. The acquisition, approved by the Board in February 2026, involves a cash consideration of ₹1,14,30,000 for 6,35,000 equity shares at ₹18 per share. Zenwatt, incorporated in July 2023, is engaged in Battery Energy Storage Systems (BESS) and reported a turnover of only ₹5,13,000 for FY 2025-26, with nil turnover in the prior two years, indicating it is a very early-stage entity.
- · The acquisition is a related party transaction as the Promoter and members of the Promoter Group have an interest in Zenwatt Clean Energy Private Limited, but it is stated to be at arm's length.
- · Zenwatt Clean Energy Private Limited was incorporated on July 7, 2023, and had nil turnover in FY 2023-24 and FY 2024-25, with only ₹5,13,000 turnover in FY 2025-26.
- · The acquisition was approved by the Board on February 9, 2026, and has now been completed.
21-09-2026
Ather Energy Limited has incorporated a wholly owned subsidiary, Ather Energy Hong Kong Limited, in Hong Kong on September 21, 2026, to support critical procurement functions and enhance supply chain resilience in the Asia-Pacific region. The subsidiary is 100% controlled by Ather Energy, with 16,50,000 ordinary shares subscribed at HKD 1 per share for cash consideration. No governmental or regulatory approvals were required for the incorporation.
- · The subsidiary is incorporated in Hong Kong, a jurisdiction outside India, indicating international expansion of procurement operations.
- · The incorporation is a cash consideration transaction, with no share swap or governmental/regulatory approvals required.
- · The subsidiary is wholly owned, giving Ather Energy 100% control, which may enhance operational flexibility in the APAC region.
21-09-2026
Dixon Technologies (India) Limited has incorporated a new subsidiary, Adivistar Electronics India Private Limited, and subscribed to 25,50,000 equity shares at par for a total cash consideration of ₹2,55,00,000 (₹2.55 Crore). The subsidiary, incorporated on 13th August 2026, will operate as an original equipment manufacturer (OEM) of electronic devices, including smartphones. This acquisition is a related-party transaction as Adivistar is a wholly-owned subsidiary of Dixon, but no promoter/group companies have any other interest in the entity.
- · Adivistar was incorporated on 13th August 2026 and has not yet commenced business; turnover is nil.
- · The acquisition is a related-party transaction as Adivistar is a subsidiary of Dixon; no promoter/group companies have any interest in the entity.
- · All requisite governmental/regulatory approvals for the acquisition have been obtained.
- · The subsidiary will focus on OEM manufacturing of electronic devices, including smartphones, in India.
21-09-2026
Rays of Belief Ltd (Mom's Belief) completed the acquisition of 100% of City Pro Group Inc. (CPG), a New York-based pediatric healthcare provider, through its wholly owned subsidiary Mom's Belief US Inc., effective September 18, 2026. The deal strengthens Mom's Belief's U.S. presence and creates a two-way India–U.S. capability exchange. While the acquisition adds a revenue-generating platform (CPG FY25 revenue of US$11.43 Mn / ~₹97.27 Cr), the combined scale is expected to significantly enhance consolidated revenue, though integration risks and regulatory approvals for cross-border practices remain.
- · CPG was founded in 1995 and operates in Bronx, Brooklyn, Manhattan and Long Island (Plainview).
- · CPG is an approved New York State Department of Health Early Intervention Program provider and a Medicaid-enrolled provider.
- · Rays of Belief FY26 EPS was ₹3.21.
- · The acquisition was completed through Mom's Belief US Inc., making CPG a step-down wholly owned subsidiary.
- · The acquisition is expected to create a two-way exchange of clinical and operating capabilities between CPG and Mom's Belief's 136-centre Indian network.
21-09-2026
Kapil Raj Finance Ltd. approved the acquisition of 90% of Henyo Pack Limited via a share swap, issuing up to 26,54,87,700 equity shares (face value ₹1 each) to Henyo's shareholders at a swap ratio of 100:1. The board also approved an increase in authorized share capital from ₹11,00,00,000 to ₹46,00,00,000, adoption of a new MOA, change in company name, and appointment of Santosh Rani as Whole-time Director. Henyo's turnover declined to ₹4,673.38 Lakh in FY 2024-25 from ₹2,836.41 Lakh in FY 2023-24, indicating a sharp drop, though the acquisition aims to diversify into the packaging segment.
- · Henyo Pack Limited was incorporated on 08/08/1997
- · The acquisition is proposed to be completed within 30 days from stock exchange approval
- · The swap ratio is 100:1 (100 equity shares of Kapil Raj for every 1 share of Henyo)
- · The company will issue up to 66,98,000 additional equity shares on preferential basis to 5 investors
- · The board approved appointment of Santosh Rani as Whole-time Director w.e.f. 21.09.2026
- · The company's authorized capital will increase from ₹11,00,00,000 to ₹46,00,00,000
- · Henyo Pack Limited's turnover declined from ₹2,986.62 Lakh in FY 2022-23 to ₹2,836.41 Lakh in FY 2023-24, a 5% drop
- · The acquisition is subject to shareholder approval at the ensuing AGM and other regulatory approvals
21-09-2026
Race Eco Chain Limited has received observation letters with 'no adverse observations' from BSE and NSE regarding its draft composite scheme of arrangement to demerge its Biomass Division into Geoeco Green Energy Limited (Resultant Company No. 1) and its Restore Bag Division into Race Gateway Limited (Resultant Company No. 2). The stock exchanges have conveyed their 'no objection' to the scheme, subject to compliance with various conditions including shareholder approvals, NCLT filing, and listing requirements. The scheme remains subject to applicable regulatory approvals, and the observation letter is valid for six months from September 21, 2026.
- · The observation letters were issued by BSE and NSE on September 21, 2026.
- · SEBI provided comments on the draft scheme via letter dated July 30, 2026, including compliance with Regulation 11 of SEBI LODR, disclosure of ongoing adjudication/recovery proceedings, and ensuring financials in the scheme are not more than 6 months old.
- · The scheme involves two demerged undertakings: Demerged Undertaking No. 1 (Biomass Division) to Geoeco Green Energy Limited, and Demerged Undertaking No. 2 (Restore Bag Division) to Race Gateway Limited.
- · The resultant companies (Geoeco and Gateway) must complete listing and commence trading within 60 days of receipt of the NCLT order.
- · The observation letter is valid for six months from September 21, 2026, within which the scheme must be submitted to NCLT.
- · The company must disclose the no-objection letter on its website within 24 hours of receipt.
- · The scheme is subject to compliance with all applicable provisions of the Companies Act, 2013, including obtaining creditor consent.
21-09-2026
Himadri Speciality Chemical Ltd (HSCL) approved a Scheme of Arrangement to demerge the Tyre Business of Dalmia Bharat Refractories Limited (DBRL) into HSCL, effective from the Appointed Date of 1 October 2026. The demerged undertaking had a turnover of INR 149.31 crore (3.39% of HSCL's total turnover) as of 31 March 2026. No cash consideration is involved; HSCL will issue new shares to DBRL shareholders, with the shareholding pattern expected to change slightly. The scheme is subject to regulatory approvals and is aimed at integrating the tyre business with HSCL's carbon black operations to create synergies and enhance strategic focus.
- · Appointed Date for the Scheme is 1 October 2026.
- · No cash consideration is involved in the Scheme; consideration is in the form of Resulting Company New Shares.
- · The shareholding pattern of the Demerged Company (DBRL) will not undergo any change.
- · The Scheme is subject to approvals from stock exchanges, SEBI, NCLT, and shareholders/creditors.
- · The Resulting Company's promoter shareholding is expected to decrease marginally from 52.49% to 52.47% post-scheme.
- · Fractional shares arising from the Scheme will be consolidated and issued to a trustee nominated by the Board.
- · The fairness opinion was issued by Jajodia Equity Advisors Services Limited (Merchant Banker) dated 20 September 2026.
- · The valuation report was issued by SSPA & Co, Chartered Accountants, dated 20 September 2026.
21-09-2026
Himadri Speciality Chemical Ltd (HSCL) has approved a Scheme of Arrangement to demerge the Tyre Business of Dalmia Bharat Refractories Limited (DBRL) into HSCL, with the demerged undertaking's turnover at INR 149.31 crore (3.39% of HSCL's total turnover). The transaction involves no cash consideration; instead, HSCL will issue new shares to eligible DBRL shareholders, subject to regulatory approvals. The demerger is expected to create synergies in the tyre value chain, but the shareholding pattern will change slightly, and the scheme is subject to approvals from stock exchanges, SEBI, NCLT, and shareholders.
- · Appointed Date for the scheme is 1 October 2026
- · No cash consideration is involved in the scheme
- · Resulting Company New Shares will be listed on BSE and NSE
- · Shareholding pattern of Demerged Company (DBRL) will not change
- · Fractional shares will be consolidated and issued to a trustee nominated by the Board
- · Fairness opinion dated 20 September 2026 issued by Jajodia Equity Advisors Services Limited
- · Valuation report dated 20 September 2026 issued by SSPA & Co
21-09-2026
Samvardhana Motherson International Limited (SAMIL) announced that its wholly owned subsidiary, Samvardhana Motherson Adsys Tech Limited (SMAST), will acquire a 50.1% equity stake in Rotary Connectors Private Limited (RCPL) for an enterprise value of INR 5,004 Million. RCPL, which manufactures military-grade circular connectors for the Aerospace and Defence sector, reported a turnover of INR 1,235 Million for FY 2026, up from INR 1,028 Million in FY 2025 and INR 752 Million in FY 2024, showing strong growth. The acquisition is expected to close by Q4 FY 2026-27 and will make RCPL an indirect subsidiary of SAMIL, with the promoters retaining a 49.9% stake.
- · The acquisition is a cash consideration deal with no governmental or regulatory approvals required.
- · Equity value will be determined as enterprise value plus net cash as on locked box date of March 31, 2026, with adjustments for leakage or cash withdrawal.
- · SMAST will have the right to appoint a majority of directors on RCPL's board.
- · RCPL was incorporated on December 8, 2005.
21-09-2026
Panorama Studios International Limited has executed an Assignment Agreement with Ultra Media and Entertainment Private Limited to acquire the dubbing rights of the film 'Anomie - The Equation of Death' in all Indian languages and dialects, excluding Tamil, Malayalam, Kannada, and Telugu. The acquisition expands Panorama's content library but financial terms were not disclosed.
- · The dubbing rights exclude Tamil, Malayalam, Kannada, and Telugu languages.
- · The agreement was executed on September 21, 2026.
- · The filing was made under Regulation 30 of the SEBI Listing Regulations.
21-09-2026
Thyrocare Technologies' Board approved the sale of its entire 100% stake in wholly owned subsidiary Nueclear Healthcare Limited (NHL) to Trovera Healthcare Private Limited for a total consideration of ₹141.40 Crore, comprising a cash component of ₹59.50 Crore and 42,500 CCPS of Trovera valued at ₹81.90 Crore. The transaction, which also includes the purchase of NHL's Gurugram and Hyderabad properties for ₹20.59 Crore, is subject to shareholder approval and is expected to complete by November 30, 2026. While the divestment allows Thyrocare to focus on its core pathology business, NHL's financial contribution is modest, with FY26 turnover of ₹44.62 Crore (5.38% of consolidated turnover) and a PAT margin of 10.9%.
- · NHL is a material wholly owned subsidiary; after sale, Thyrocare will cease control over NHL.
- · The transaction is a slump sale and not an amalgamation/merger.
- · Trovera was incorporated on June 16, 2026 and has no audited financials for the preceding three years.
- · The CCPS have a face value of ₹10 each and are issued at a premium of ₹14,000 per CCPS.
- · The acquisition of CCPS is conditional upon completion of the NHL sale, which requires shareholder approval via special resolution.
- · The purchase of NHL's properties is exclusive of stamp duty and registration charges.
- · The Board meeting commenced at 2:15 PM on September 21, 2026.
- · The transaction is not a related party transaction; Trovera is not a promoter group company.
- · Expected completion date is on or before November 30, 2026, subject to conditions precedent.
Get daily alerts with 12 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 14 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Sector Consolidation Regulatory Filings
September 17, 2026
India Sector Consolidation Regulatory Filings — September 17, 2026
September 15, 2026
India Sector Consolidation Regulatory Filings — September 15, 2026
September 14, 2026
India Sector Consolidation Regulatory Filings — September 14, 2026
September 13, 2026
India Sector Consolidation Regulatory Filings — September 13, 2026
🇮🇳 More from India
View all →September 21, 2026
India Upcoming Corporate Actions BSE NSE — September 21, 2026
India Upcoming Corporate Actions BSE NSE
September 21, 2026
India Pre-Market Regulatory Roundup — September 21, 2026
India Pre-Market Regulatory Roundup
September 21, 2026
India Quarterly Results BSE NSE Announcements — September 21, 2026
India Quarterly Results BSE NSE Announcements
September 21, 2026
India AGM EGM Shareholder Meeting Schedule — September 21, 2026
India AGM EGM Shareholder Meeting Schedule